| Code | 4876D | ||||||||||
| MA number | EU/1/20/1436/003 | ||||||||||
| Product Form: | sol inj 4x1 ml/50 mg (striek.inj.napl.skl.) | ||||||||||
| MA Status: | E - Valid centralised marketing authorisation | ||||||||||
| Type of procedure: | EU | ||||||||||
| MAH, country: | Biosimilar Collaborations Ireland Limited, Ireland | ||||||||||
| Therapeutic Class: | 59 - IMMUNOPRAEPARATA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 36 | ||||||||||
| Route of admin.: | Subcutaneous use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10(4) similar biological application |
| MA issued: | 20.05.2020 |
| Validity: | 20.05.2025 |
| SmPC + PL: |
European Medicines Agency's database
|
| Safety feature | Yes |
| Data update: | 08.09.2023 |
